TABLE 5.
Cognitive measure | Plasma category (adequate/inadequate) | Gender | Sample size, n | Mean | SE | 95% CI |
---|---|---|---|---|---|---|
Trial 1 | Adequate | Male | 27 | 6.89↓ | 0.38 | 6.15, 7.65 |
Female | 53 | 7.73 | 0.25 | 7.32, 8.23 | ||
Inadequate | Male | 7 | 6.82↓ | 0.66 | 5.61, 8.03 | |
Female | 6 | 6.99 | 0.69 | 5.51, 8.57 | ||
Trial 2 | Adequate | Male | 27 | 9.56↓ | 0.39 | 8.78, 10.32 |
Female | 53 | 9.80 | 0.26 | 9.30, 10.31 | ||
Inadequate | Male | 27 | 8.67 | 0.62 | 7.44, 9.90 | |
Female | 53 | 7.96↓ | 0.78 | 6.40, 9.53 | ||
Trial 3 | Adequate | Male | 27 | 10.55↓ | 0.30 | 9.96, 11.13 |
Female | 53 | 10.64 | 0.20 | 10.25, 11.03 | ||
Inadequate | Male | 7 | 9.29↓ | 0.47 | 8.36, 10.23 | |
Female | 6 | 9.35 | 0.60 | 8.16, 10.15 | ||
Total recall | Adequate | Male | 27 | 26.95↓ | 0.88 | 25.20, 28.70 |
Female | 53 | 28.26 | 0.58 | 27.10, 29.41 | ||
Inadequate | Male | 7 | 24.70 | 1.41 | 21.90, 27.51 | |
Female | 6 | 24.26↓ | 1.78 | 20.70, 27.81 | ||
Delayed recall | Adequate | Male | 27 | 9.98 | 0.39 | 9.21, 10.76 |
Female | 53 | 9.54↓ | 0.26 | 9.02, 10.05 | ||
Inadequate | Male | 7 | 7.72↓ | 0.68 | 6.36, 9.08 | |
Female | 6 | 8.33 | 0.71 | 6.90, 9.75 | ||
Recognition index | Adequate | Male | 27 | 10.84↓ | 0.26 | 10.32, 11.36 |
Female | 53 | 11.56 | 0.17 | 11.22, 11.90 | ||
Inadequate | Male | 7 | 10.59 | 0.46 | 9.68, 11.50 | |
Female | 6 | 10.29↓ | 0.48 | 9.34, 11.24 | ||
SDMT | Adequate | Male | 27 | 47.98↓ | 1.79 | 44.42, 52.14 |
Female | 53 | 49.76 | 1.18 | 47.41, 52.11 | ||
Inadequate | Male | 7 | 47.46 | 3.13 | 41.25, 53.71 | |
Female | 6 | 40.87↓ | 3.67 | 33.34, 46.36 |
HVLT-R, Hopkins Verbal Learning Test–Revised; SDMT, Symbol Digits Modalities Test; ↓, lower mean value between genders (male/female) for vitamin C subgroup (adequate/inadequate).